Literature DB >> 27352590

[Polypharmacy, the new epidemic].

Stefan Neuner-Jehle.   

Abstract

Polypharmacy is an increasing problem in the care of multimorbide patients, and increases morbidity, mortality, hospitalization rates and costs. A promising intervention against polypharmacy is the systematic listing of all drugs taken by the patient with critical appraisal of indication, side effects, dosage and alternatives of every single drug. It is necessary to consider and to discuss priorities and preferences of patients in regard to treatment goals. A clear medication plan is needed after shared decision making with the patient. We present some helpful tools for this purpose. Further challenges besides an empathic communication with the patient are finding enough time in the clinical encounter, the integration of other health professionals and computer-assisted solutions in primary care practices and hospitals.

Entities:  

Mesh:

Year:  2016        PMID: 27352590

Source DB:  PubMed          Journal:  Rev Med Suisse        ISSN: 1660-9379


  2 in total

1.  Adverse Drug Reactions Involving Protein Kinase Inhibitors: A French Pharmacovigilance Database Study Comparing Safety in Younger and Older Patients (≥ 75 years) with Cancer.

Authors:  Vincent Clapes; Vanessa Rousseau; Fabien Despas; Jean-Louis Montastruc; Pascale Olivier
Journal:  Pharmaceut Med       Date:  2019-02

2.  Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study.

Authors:  Julien Castioni; Pedro Marques-Vidal; Nazanin Abolhassani; Peter Vollenweider; Gérard Waeber
Journal:  BMC Health Serv Res       Date:  2017-12-21       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.